Gamida for Life

Gamida for Life is a multinational healthcare consortium and holding company headquartered in the Netherlands, with a significant operational presence in Israel and across Europe. Established in 1976, the group operates through several specialized subsidiaries, including Gamidor Diagnostics, Danyel Biotech, and Savyon Diagnostics, focusing on the distribution and development of medical devices, life science research tools, and in-vitro diagnostics. The company provides a comprehensive range of products and services to clinical laboratories, hospitals, and academic research institutes, covering fields such as oncology, genetics, and infectious diseases. Through its strategic partnership in Ador Diagnostics, Gamida for Life is advancing the NATlab platform, a novel point-of-care molecular diagnostic system utilizing isothermal amplification technology. Historically, the group played a foundational role in the establishment of Gamida Cell, a leader in cell therapy.